MGRN:通过多视图门检索网络实现强有力的药物推
Fanjun Meng1, Xiaobo Li2, Xiaodi Hou1
1School of Artificial Intelligence, Dalian Maritime University, 116026 Dalian, China.
Bioinformatics (Oxford, England)
|September 24, 2024
概括
这项研究引入了一种新的多视图门检索网络 (MGRN),用于改进药物推系统. MGRN增强了患者健康状况表示和药物历史建模,从而导致更准确和更有效的药物组合建议.
科学领域:
- 医疗信息学 医疗信息学
- 医疗保健中的人工智能
- 临床决策支持系统 临床决策支持系统
背景情况:
- 药物推系统旨在使用电子健康记录识别安全有效的药物组合.
- 现有的系统在全面的患者健康状况表示和患者药物史建模方面扎.
研究的目的:
- 为了解决当前药物推方法的局限性.
- 在临床实践中开发一个可靠的模型,以改善药物组合建议.
主要方法:
- 提出了一个多视图门检索网络 (MGRN).
- 集成的访问,序列和令牌级别视图,以提供全面的药物表示.
- 开发了一个门禁药物检索模块,以利用历史药物信息.
主要成果:
- 在MIMIC-III和MIMIC-IV数据集上,MGRN实现了新的基准性能.
- 在Jaccard,PRAUC和F1得分指标中显著改善.
- 在药物推准确性方面表现优于最先进的模型.
结论:
- MGRN提供了一种更强大,更全面的药物推方法.
- 该模型有效地捕捉了患者的健康状况和药物史,以更好地支持临床决策.
- 拟议的方法为基于电子健康记录的药物推制定了新的标准.
相关概念视频
ER Retrieval Pathway
In the secretory pathway, vesicles transport proteins from one cellular compartment to another in forward transport to deliver the protein to its correct location. Occasionally, misfolded proteins and incorrect proteins escape their original compartments, and a retrieval pathway is used to return the escaped proteins to their original compartment.
The ER uses many checkpoints to prevent the entry of incorrectly folded or a resident protein as cargo onto a transport vesicle. These mechanisms...
The ER uses many checkpoints to prevent the entry of incorrectly folded or a resident protein as cargo onto a transport vesicle. These mechanisms...
G Protein-coupled Receptors
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Therapeutic Drug Monitoring: Overview and Classification
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Pharmacodynamic Models: Additive and Proportional Drug Effect Model
Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).


